Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.


“MedCity news is a peerless national resource for those of us who really want to stay on top the very latest news in healthcare from incumbents to startups. ”

Elliot Menschik, DreamIt Ventures partner; Venturef0rth founder; Penn professor


Sign up for our daily newsletter


Gilead to buy YM BioSciences for about $465 million

December 12, 2012 11:06 am by | 0 Comments

(Reuters) - Gilead Sciences Inc will buy Canada's YM BioSciences Inc for about $465 million to gain access to its blood and immune cell disorder drugs.

Gilead said it will pay $2.95 per YM share.

YM shares closed at C$1.66 on Tuesday on the Toronto Stock Exchange.

(Reporting by Adithya Venkatesan and Shounak Dasgupta in Bangalore; Editing by Roshni Menon)

Advertisement

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
0 comments